A new blood test has been developed that claims to diagnose preeclampsia with 99% accuracy and predict its occurrence with 38.4% accuracy. The test, developed by Roche Diagnostics Korea, is performed between 20 and 34 weeks of pregnancy in an attempt to minimize the risks of injury to the mother and baby. Choi Su-hee, Roche Diagnostics Korea’s product manager says, “Pregnant women diagnosed with preeclampsia have low levels of PlGF and high levels of sFlt-1. By measuring the two [in a blood test], we can diagnose preeclampsia.” To date, preeclampsia has been diagnosed by high levels of protein in the urine as well as high blood pressure—conditions, however, that may also be present without the occurrence of preeclampsia.
If you experienced preeclampsia during your pregnancy and your child has suffered as a result, please contact our lawyers at 877-262-9767.
The following reviews from our clients do not constitute a guarantee, warranty, or prediction regarding the outcome of another legal matter. The cases mentioned in the reviews are illustrative of some of the matters previously handled by Grant & Eisenhofer involving various areas of birth injury law. These reviews are endorsements.
The following reviews from our clients do not constitute a guarantee, warranty, or prediction regarding the outcome of another legal matter. The cases mentioned in the reviews are illustrative of some of the matters previously handled by Grant & Eisenhofer involving various areas of birth injury law. These reviews are endorsements.